Navigation Links
Dilon Technologies' Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
Date:2/3/2009

NEWPORT NEWS, Va., Feb. 3 /PRNewswire/ -- Dilon Technologies, Inc., a leader in molecular breast imaging, today announced the release of two new collimators: the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator. Both collimators are attachment options for the Dilon 6800 Gamma Camera that help to optimize imaging for the respective applications.

The Slant15 Collimator is a 15-degree slant parallel-hole collimator that minimizes the dead space along the edge of the detector, allowing better visualization of the chest wall in breast imaging. Uses include: breast imaging; sentinel node imaging; thyroid imaging; and parathyroid imaging.

LEHR collimator is a high-resolution collimator for general nuclear medicine applications. Uses include thyroid imaging, parathyroid imaging, sentinel node imaging, spot bone imaging, gall bladder ejection, and pediatric imaging studies.

"With the release of these new collimators, we are expanding breast imaging and general nuclear applications for the Dilon 6800 Gamma," said Bob Moussa, President and CEO of Dilon Technologies. "This is another step in providing a broader service offering to clinicians."

About Dilon Technologies

Dilon Technologies, Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston.

For more information on Dilon Technologies please visit http://www.dilon.com.


'/>"/>
SOURCE Dilon Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
2. Dilon Technologies Announces National Agreement with MedAssets
3. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
4. Dilon Technologies Appoints New VP of Sales & Business Development
5. Dilon Technologies Explores Improvements in Molecular Breast Imaging
6. Patient Safety Technologies Closes $2.55 Million Financing
7. Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009
8. Medusa Medical Technologies Announces Integration of Siren ePCR Suite(TM) with Philips HeartStart MRx Monitor/Defibrillator
9. Global Med Technologies(R) Licenses Multi-System Solution to One of Top Ten U.S. Donor Centers
10. VNUS Medical Technologies to Report Fourth-Quarter 2008 Results and Webcast Teleconference on February 10
11. MedClean Technologies Inc. Announces New Ticker Symbol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: